Contract 75A50123C00039
Eradivir Inc · Department Of Health And Human Services · September 10, 2024
Eradivir Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 10, 2024 for $749,000 (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Collegeville, PA. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $749,000.
Contract details
- PIID
- 75A50123C00039
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Collegeville, PA
- First action
- September 10, 2024
Description
ERADIVIR INC. IND STUDIES IS TO COMPLETE A PACKAGE OF GLP-COMPLIANT NONCLINICAL SAFETY STUDIES THAT WILL SUPPORT A SUCCESSFUL INITIAL IND APPLICATION
Modification timeline
-
September 10, 2024Mod P00003 · Supplemental Agreement For Work Within Scope$749.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50123C00039?
Contract 75A50123C00039 is a federal contract awarded to Eradivir Inc by Department Of Health And Human Services on September 10, 2024 for $749,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75A50123C00039?
Eradivir Inc won contract 75A50123C00039 from Department Of Health And Human Services.
How much is contract 75A50123C00039 worth?
Contract 75A50123C00039 has obligated $0 to date but carries a potential ceiling of $749,000 if fully funded and all options are exercised.